Literature DB >> 2614683

Optimal design allocations for estimating area under curves for studies employing destructive sampling.

W W Piegorsch1, A J Bailer.   

Abstract

Optimal allocations of experimental resources for the estimation of integrals is considered for experiments that use destructive sampling. Given a set of sampling times, a minimum mean square error rule is given for the allotment of fixed experimental resources to the independent variable. The results are seen to be functionally dependent upon the pattern of underlying variability assumed in the model and upon the quadrature rule used to estimate the integral. Extensions to other optimality criteria, including a minimum mean absolute deviation criterion, and to cases involving multiple treatment groups, are also noted.

Mesh:

Year:  1989        PMID: 2614683     DOI: 10.1007/bf01061459

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  10 in total

1.  Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin.

Authors:  J G Wagner; J W Ayres
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

2.  Statistical aspects of comparative bioavailability trials.

Authors:  W J Westlake
Journal:  Biometrics       Date:  1979-03       Impact factor: 2.571

3.  Choosing optimal sampling times for therapeutic drug monitoring.

Authors:  G E Schumacher
Journal:  Clin Pharm       Date:  1985 Jan-Feb

4.  Testing for the equality of area under the curves when using destructive measurement techniques.

Authors:  A J Bailer
Journal:  J Pharmacokinet Biopharm       Date:  1988-06

5.  Experimental design for estimating integrals by numerical quadrature, with applications to pharmacokinetic studies.

Authors:  D Katz; D Z D'Argenio
Journal:  Biometrics       Date:  1983-09       Impact factor: 2.571

6.  Optimal designs for the analysis of interactive effects of two carcinogens or other toxicants.

Authors:  J Wahrendorf; R Zentgraf; C C Brown
Journal:  Biometrics       Date:  1981-03       Impact factor: 2.571

7.  Distribution and excretion of 2,3,6,2',3',6'- and 2,4,5,2',4',5'-hexachlorobiphenyl in senescent rats.

Authors:  L S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  1983-09-15       Impact factor: 4.219

8.  The inhalation toxicity of two commercial dyes: solvent yellow 33 and solvent green 3.

Authors:  J D Sun; R F Henderson; T C Marshall; Y S Cheng; J S Dutcher; J A Pickrell; J L Mauderly; F F Hahn; D A Banas; F A Seiler
Journal:  Fundam Appl Toxicol       Date:  1987-04

9.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.

Authors:  M E Andersen; H J Clewell; M L Gargas; F A Smith; R H Reitz
Journal:  Toxicol Appl Pharmacol       Date:  1987-02       Impact factor: 4.219

10.  Disposition and metabolism of 2-bromo-4,6-dinitroaniline in the male F344 rat.

Authors:  H M Chopade; H B Matthews
Journal:  J Toxicol Environ Health       Date:  1986
  10 in total
  3 in total

1.  Construction of an optimal destructive sampling design for noncompartmental AUC estimation.

Authors:  F Vandenhende; M Comblain; M H Delsemme; W Dewe; W P Hoffman; B Boulanger
Journal:  J Pharmacokinet Biopharm       Date:  1999-04

2.  Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs.

Authors:  Martin J Wolfsegger; Thomas Jaki
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-10-22       Impact factor: 2.745

3.  An analysis of errors arising from the direct use of mass balance principles to describe regional drug uptake and elution.

Authors:  R N Upton
Journal:  J Pharmacokinet Biopharm       Date:  1994-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.